AAAAAA

   
Results: 1-16 |
Results: 16

Authors: Weiskirch, LM Pan, ZK Paterson, Y
Citation: Lm. Weiskirch et al., The tumor recall response of antitumor immunity primed by a live, recombinant Listeria monocytogenes vaccine comprises multiple effector mechanisms, CLIN IMMUNO, 98(3), 2001, pp. 346-357

Authors: Gerard, CM Baudson, N Kraemer, K Bruck, C Garcon, N Paterson, Y Pan, ZK Pardoll, D
Citation: Cm. Gerard et al., Therapeutic potential of protein and adjuvant vaccinations on tumour growth, VACCINE, 19(17-19), 2001, pp. 2583-2589

Authors: Mata, M Yao, ZJ Zubair, A Syres, K Paterson, Y
Citation: M. Mata et al., Evaluation of a recombinant Listeria monocytogenes expressing an HIV protein that protects mice against viral challenge, VACCINE, 19(11-12), 2001, pp. 1435-1445

Authors: Beatty, GL Paterson, Y
Citation: Gl. Beatty et Y. Paterson, Regulation of tumor growth by IFN-gamma in cancer immunotherapy, IMMUNOL RES, 24(2), 2001, pp. 201-210

Authors: Lamikanra, A Pan, ZK Isaacs, SN Wu, TC Paterson, Y
Citation: A. Lamikanra et al., Regression of established human papillomavirus type 16 (HPV-16) immortalized tumors in vivo by vaccinia viruses expressing different forms of HPV-16 E7 correlates with enhanced CD8(+) T-cell responses that home to the tumor site, J VIROLOGY, 75(20), 2001, pp. 9654-9664

Authors: Matthews, AE Weiss, SR Shlomchik, MJ Hannum, LG Gombold, JL Paterson, Y
Citation: Ae. Matthews et al., Antibody is required for clearance of infectious murine hepatitis virus A59 from the central nervous system, but not the liver, J IMMUNOL, 167(9), 2001, pp. 5254-5263

Authors: Gunn, GR Zubair, A Peters, C Pan, ZK Wu, TC Paterson, Y
Citation: Gr. Gunn et al., Two Listeria monocytogenes vaccine vectors that express different molecular forms of human papilloma virus-16 (HPV-16) E7 induce qualitatively different T cell immunity that correlates with their ability to induce regressionof established tumors immortalized by HPV-16, J IMMUNOL, 167(11), 2001, pp. 6471-6479

Authors: Beatty, GL Paterson, Y
Citation: Gl. Beatty et Y. Paterson, IFN-gamma-dependent inhibition of tumor angiogenesis by tumor-infiltratingCD4(+) T cells requires tumor responsiveness to IFN-gamma, J IMMUNOL, 166(4), 2001, pp. 2276-2282

Authors: Argyris, EG Vanderkooi, JM Paterson, Y
Citation: Eg. Argyris et al., Mutagenesis of key residues identifies the connection subdomain of HIV-1 reverse transcriptase as the site of inhibition by heme, EUR J BIOCH, 268(4), 2001, pp. 925-931

Authors: Beatty, GL Paterson, Y
Citation: Gl. Beatty et Y. Paterson, IFN-gamma can promote tumor evasion of the immune system in vivo by down-regulating cellular levels of an endogenous tumor antigen, J IMMUNOL, 165(10), 2000, pp. 5502-5508

Authors: Mata, M Paterson, Y
Citation: M. Mata et Y. Paterson, Th1 T cell responses to HIV-1 Gag protein delivered by a Listeria monocytogenes vaccine are similar to those induced by endogenous listerial antigens, J IMMUNOL, 163(3), 1999, pp. 1449-1456

Authors: Saito, NG Chang, HC Paterson, Y
Citation: Ng. Saito et al., Recognition of an MHC class I-restricted antigenic peptide can be modulated by para-substitution of its buried tyrosine residues in a TCR-specific manner, J IMMUNOL, 162(10), 1999, pp. 5998-6008

Authors: Argyris, EG Vanderkooi, JM Venkateswaran, PS Kay, BK Paterson, Y
Citation: Eg. Argyris et al., The connection domain is implicated in metalloporphyrin binding and inhibition of HIV reverse transcriptase, J BIOL CHEM, 274(3), 1999, pp. 1549-1556

Authors: Pan, ZK Weiskirch, LM Paterson, Y
Citation: Zk. Pan et al., Regression of established B16F10 melanoma with a recombinant Listeria monocytogenes vaccine, CANCER RES, 59(20), 1999, pp. 5264-5269

Authors: Paterson, Y
Citation: Y. Paterson, The relationship between intracellular bacterial life-styles and immune responsiveness to bacterial delivered antigens, INTRACELLULAR BACTERIAL VACCINE VECTORS, 1999, pp. 1-24

Authors: Weiskirch, LM Paterson, Y
Citation: Lm. Weiskirch et Y. Paterson, The use of Listeria monocytogenes recombinants as vaccine vectors in infectious and neoplastic disease, INTRACELLULAR BACTERIAL VACCINE VECTORS, 1999, pp. 223-259
Risultati: 1-16 |